CD4 and neoplasm: Bruno and colleagues demonstrated that tumor-infiltrating B cells efficiently presented antigens to CD4+ TILs and identified three CD4+ TIL responses to tumor-infiltrating B cells, which were categorized as activated, antigen-associated, and nonresponsive [15].